Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what plans he has to improve (a) the diagnosis rate of Hereditary Spastic Paraplegia and (b) the co-ordination of care and access to specialist care, treatment and support for people with HSP.

Genomic testing for patients with hereditary spastic paraplegia is available on the Test Directory. Seven NHS Genomic Medicine Service (GMS) Alliances play an important role in supporting the strategic systematic embedding of genomic medicine in end-to-end clinical pathways and clinical specialities, as well as raising awareness among clinicians and the public of the genomic testing available through the NHS. More broadly, the government’s UK Rare Diseases Framework sets out four key priorities for improving the lives of people living with rare diseases, such as hereditary spastic paraplegia, which include faster diagnosis, better coordination of care and improved access to specialist care, treatment and drugs.